Myocardial transcription factors are modulated during pathologic cardiac hypertrophy in vivo

Journal of Thoracic and Cardiovascular Surgery

Volumn 132, Issue 6, 2006, Pages

  Azakie, Anthony ^a   Fineman, Jeffrey R ^a   He, Youping ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; MYOCYTE ENHANCER FACTOR 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRANSCRIPTIONAL ENHANCER FACTOR 1; TROPONIN T;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DELIVERY; ENZYME ACTIVITY; EXPERIMENTAL MODEL; FAILURE TO THRIVE; FEMALE; GENE ACTIVITY; GENE CONSTRUCT; GENE REPRESSION; GENETIC TRANSFECTION; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE; HEART VENTRICLE HYPERTROPHY; MOLECULAR WEIGHT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; SHEEP; SHUNTING; TRANSCRIPTION INITIATION;

EID: 33751396373     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.08.005     Document Type: Article

References (30)

1. Hunter J.J., and Chien K.R. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 341 (1999) 1276-1283
2. Chien K.R. Stress pathways and heart failure. Cell 98 (1999) 555-558
3. McKinsey T.A., and Olson E.N. Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J Clin Invest 115 (2005) 538-546
4. Backs J., and Olson E.N. Control of cardiac growth by histone acetylation/deacetylation. Circ Res 98 (2006) 15-24
5. Charron F., and Nemer M. GATA transcription factors and cardiac development. Semin Cell Dev Biol 10 (1999) 85-91
6. Jamali M., Rogerson P.J., Wilton S., and Skerjanc I.S. Nkx2-5 activity is essential for cardiomyogenesis. J Biol Chem 276 (2001) 42252-42258
7. Martin J.F., Schwarz J.J., and Olson E.N. Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors. Proc Natl Acad Sci U S A 90 (1993) 5282-5286
8. McBride K., and Nemer M. Regulation of the ANF and BNP promoters by GATA factors: lessons learned for cardiac transcription. Can J Physiol Pharmacol 79 (2001) 673-681
9. Azakie A., Lamont L., Fineman J.R., and He Y. Divergent transcriptional enhancer factor-1 regulates the cardiac troponin T promoter. Am J Physiol Cell Physiol 289 (2005) C1522-C1534
10. Azakie A., Larkin S.B., Farrance I.K., Grenningloh G., and Ordahl C.P. DTEF-1, a novel member of the transcription enhancer factor-1 (TEF-1) multigene family. J Biol Chem 271 (1996) 8260-8265
11. Chien K.R., Knowlton K.U., Zhu H., and Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. Faseb J 5 (1991) 3037-3046
12. McKinsey T.A., and Olson E.N. Cardiac histone acetylation-therapeutic opportunities abound. Trends Genet 20 (2004) 206-213
13. Yanazume T., Hasegawa K., Morimoto T., Kawamura T., Wada H., Matsumori A., et al. Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol Cell Biol 23 (2003) 3593-3606
14. Zhang C.L., McKinsey T.A., Chang S., Antos C.L., Hill J.A., and Olson E.N. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110 (2002) 479-488
15. Kee H.J., Sohn I.S., Nam K.I., Park J.E., Qian Y.R., Yin Z., et al. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation 113 (2006) 51-59
16. Chen F., Kook H., Milewski R., Gitler A.D., Lu M.M., Li J., et al. Hop is an unusual homeobox gene that modulates cardiac development. Cell 110 (2002) 713-723
17. Lau O.D., Kundu T.K., Soccio R.E., Ait-Si-Ali S., Khalil E.M., Vassilev A., et al. HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. Mol Cell 5 (2000) 589-595
18. de Ruijter A.J., van Gennip A.H., Caron H.N., Kemp S., and van Kuilenburg A.B. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370 (2003) 737-749
19. Antos C.L., McKinsey T.A., Dreitz M., Hollingsworth L.M., Zhang C.L., Schreiber K., et al. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J Biol Chem 278 (2003) 28930-28937
20. Kong Y., Tannous P., Lu G., Berenji K., Rothermel B.A., Olson E.N., et al. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113 (2006) 2579-2588
21. Reddy V.M., Meyrick B., Wong J., Khoor A., Liddicoat J.R., Hanley F.L., et al. In utero placement of aortopulmonary shunts. A model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs. Circulation 92 (1995) 606-613
22. Cripps R.M., Zhao B., and Olson E.N. Transcription of the myogenic regulatory gene Mef2 in cardiac, somatic, and visceral muscle cell lineages is regulated by a Tinman-dependent core enhancer. Dev Biol 215 (1999) 420-430
23. Han Z., and Olson E.N. Hand is a direct target of Tinman and GATA factors during Drosophila cardiogenesis and hematopoiesis. Development 132 (2005) 3525-3536
24. Harvey R.P. NK-2 homeobox genes and heart development. Dev Biol 178 (1996) 203-216
25. Olson E.N., Perry M., and Schulz R.A. Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors. Dev Biol 172 (1995) 2-14
26. Kim M.Y., Mauro S., Gevry N., Lis J.T., and Kraus W.L. NAD+-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1. Cell 119 (2004) 803-814
27. Farrance I.K., and Ordahl C.P. The role of transcription enhancer factor-1 (TEF-1) related proteins in the formation of M-CAT binding complexes in muscle and non-muscle tissues. J Biol Chem 271 (1996) 8266-8274
28. Butler A.J., and Ordahl C.P. Poly(ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription. Mol Cell Biol 19 (1999) 296-306
29. Szabo C. Cardioprotective effects of poly(ADP-ribose) polymerase inhibition. Pharmacol Res 52 (2005) 34-43
30. Azakie A., Fineman J.R., and He Y. Sp3 inhibits Sp1 mediated activation of the cardiac troponin T promoter and is downregulated during pathologic cardiac hypertrophy in vivo. Am J Physiol Heart Circ Physiol 291 (2006) H600-H611